Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

Y. Hu,L. Wu,B. Xu
DOI: https://doi.org/10.1016/j.ijid.2012.05.066
IF: 12.073
2012-01-01
International Journal of Infectious Diseases
Abstract:Background: Continuous understanding of the epidemiology and evolution of multidrug resistant TB (MDR-TB) is key to develop the appropriate strategies for preventing its epidemic. The present study aimed to investigate the longitudinal trend of its rates, transmissions and transition to extensively drug resistant TB(XDR-TB), in an attempt to adjust the TB control activities in eastern rural China. Methods: The data presented here span 8 years (2003-2010) and consisted of three population-based investigation of drug resistant TB in terms of socio-demographic and clinical characteristics of drug resistant TB cases as well as the microbiological and molecular features of their infected Mtb strains, respectively in one 19 years’ DOTS covered eastern rural county: Deqing (DQ) and the other 9 years’ DOTS covered Guanyun (GY). Results: Within 9 years’ study, 901 TB patients were identified at local TB dispensaries in two counties, with 254 resistant to at least one of 1st line drugs. Of the 135 MDR-TB isolates, 6 were XDR-TB. Rate of drug resistant TB remained stable, even reduced in some period both in two counties, while the rate of MDR-TB and MDR-TB plus resistance to fluoroquinolones increased significantly respectively from 14.5% and 5.1% in 2003/2004 to 21.3% and 9.7% in 2009/2010. The IS6110 RFLP genotyping revealed the 21 clusters involving 48(28.4%) drug resistant TB cases in DQ and 28 clusters involving 59(32.1%) drug resistant TB cases in GY. The clustering proportion increased among the drug resistant TB cases especially for MDR-TB over the study period, reaching 52%(DQ) and 48%(GY) in 2010. And 2 XDR-TB isolates was identified within only 2 clusters 0f drug resistant Mtb in DQ. Designated as subtypes of Beijing family, totally 3 clusters (11 drug resistant TB cases) typical with katG315Thr mutation, persisted throughout the study period in two counties. Conclusion: A high increased recent transmission of MDR-TB might implicate it necessary to improve the effectiveness on diagnosis and treatment of MDR-TB. Despite an increasing trend of MDR plus the resistant to fluoroquinolones, the low proportion of XDR-TB among MDR-TB might indicate it neccessary to cautiously introduce some of 2 line drugs in MDR-TB treatment in China.
What problem does this paper attempt to address?